Citation Impact
Citing Papers
β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors
2003
Innervation of ectopic endometrium in a rat model of endometriosis
2004
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
2005 Standout
β-arrestins: traffic cops of cell signaling
2004 StandoutNobel
G-protein-coupled Receptor Kinase Specificity for β-Arrestin Recruitment to the β2-Adrenergic Receptor Revealed by Fluorescence Resonance Energy Transfer
2006 StandoutNobel
G protein coupled receptor structure and activation
2006 StandoutNobel
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts
2007 Standout
Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis
1997
Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure
1998
Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation
2006 StandoutNobel
Multisite Pacing for End‐Stage Heart Failure: Early Experience
1996
β-Arrestin-biased Agonism at the β2-Adrenergic Receptor
2007 StandoutNobel
Structure and Conformational Changes in the C-terminal Domain of the β2-Adrenoceptor
2007 StandoutNobel
Endometriosis
2009 Standout
Neural mechanisms of atrial arrhythmias
2011
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
1995 Standout
Probing the β2 Adrenoceptor Binding Site with Catechol Reveals Differences in Binding and Activation by Agonists and Partial Agonists
2005 StandoutNobel
GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
2006 StandoutNobel
Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction
1994
A Randomized Controlled Phase IIb Trial of Beta1-Receptor Blockade for Chronic Degenerative Mitral Regurgitation
2012
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
2005 Standout
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Agonist Binding: A Multistep Process
2004 StandoutNobel
Photodynamic therapy for cancer
2003 Standout
Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart
1997
Photodynamic therapy: Applications in atherosclerotic vascular disease with motexafin lutetium
2002
Crystal structure of the β2 adrenergic receptor–Gs protein complex
2011 StandoutNatureNobel
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
The structure and function of G-protein-coupled receptors
2009 StandoutNatureNobel
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Conformational complexity of G-protein-coupled receptors
2007 StandoutNobel
Biphasic protective effect of oxytocin on cardiac ischemia/reperfusion injury in anaesthetized rats
2009
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Structural insights into adrenergic receptor function and pharmacology
2011 StandoutNobel
Clinical relevance of cardiac arrhythmias generated by afterdepolarizations
1994
Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heart
2007
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
1995 Standout
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
2007 Standout
New Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors
2006 StandoutNobel
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors
2008 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation.
1992
Atrial Fibrillation Begets Atrial Fibrillation
1995 Standout
Bradykinin Antagonism Inhibits the Antigrowth Effect of Converting Enzyme Inhibition in the Dog Myocardium After Discrete Transmural Myocardial Necrosis
1995
Extracellular Matrix Remodeling in Heart Failure
1997
Extracardiac Progenitor Cells Repopulate Most Major Cell Types in the Transplanted Human Heart
2005
β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes
2006 StandoutNobel
β-Arrestins and Cell Signaling
2007 StandoutNobel
Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor
2005 StandoutNobel
Cardiac sympathetic innervation via middle cervical and stellate ganglia and antiarrhythmic mechanism of bilateral stellectomy
2016
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
1993
Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
2003 Standout
Collagen Scar Formation After Acute Myocardial Infarction
1997
Intrinsic Cardiac Nerve Activity and Paroxysmal Atrial Tachyarrhythmia in Ambulatory Dogs
2010
Near Infrared Imaging and Photothermal Ablation of Vascular Inflammation Using Single‐Walled Carbon Nanotubes
2012
Cellular and Ionic Basis of Arrhythmias in Postinfarction Remodeled Ventricular Myocardium
1996
Therapeutic Potential of Phosphodiesterase 5 Inhibition for Cardiovascular Disease
2003
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex
2009 StandoutNobel
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure
2000 Standout
Acute and chronic NOS inhibition enhances α2- adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta
2002
Transduction of Receptor Signals by ß-Arrestins
2005 StandoutScienceNobel
Works of René Cardinal being referenced
Distinct Activation Patterns of Idioventricular Rhythms and Sympathetically‐Induced Ventricular Tachycardias in Dogs with Atrioventricular Block
1992
Post-Ischemic Cardioprotection by A2A Adenosine Receptors: Dependent of Phosphatidylinositol 3-Kinase Pathway
2004
The heart reinnervates after transplantation
2000
Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis
1991
Dorsal spinal cord stimulation obtunds the capacity of intrathoracic extracardiac neurons to transduce myocardial ischemia
2009
Origin and pharmacological response of atrial tachyarrhythmias induced by activation of mediastinal nerves in canines
2005
Chronic spinal cord stimulation modifies intrinsic cardiac synaptic efficacy in the suppression of atrial fibrillation
2014
β1- Adrenoceptor blockade mitigates excessive norepinephrine release into cardiac interstitium in mitral regurgitation in dog
2006
Sustained Cardioprotection Afforded by A2A Adenosine Receptor Stimulation After 72 Hours of Myocardial Reperfusion
2005
Three Distinct Patterns of Ventricular Activation in Infarcted Human Hearts
1995
Functional desensitization to isoproterenol without reducing cAMP production in canine failing cardiocytes
2001
Relationship Between an Arrhythmogenic Action of Lidocaine and Its Effects on Excitation Patterns in Acutely Ischemic Porcine Myocardium
1986
Negative Inotropic and Chronotropic Effects of Oxytocin
2001
Sildenafil (Viagra) Prolongs Cardiac Repolarization by Blocking the Rapid Component of the Delayed Rectifier Potassium Current
2000
Mapping of ventricular tachycardia induced by thoracic neural stimulation in dogs
1986
Markedly different effects on ventricular remodelling result in a decrease in inducibility of ventricular arrhythmias
1994
Sympathetic functions in NG-nitro-L-arginine-methylester-induced hypertension
1998